• Guardant Health Inc GH.OQ reported a quarterly adjusted loss of 84 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -94 cents. The mean expectation of twenty four analysts for the quarter was for a loss of 81 cents per share. Wall Street expected results to range from $-1.01 to -55 cents per share.

• Revenue rose 20.8% to $203.47 million from a year ago; analysts expected $190.12 million.

• Guardant Health Inc's reported EPS for the quarter was a loss of 77 cents​.

• The company reported a quarterly loss of $95.16 million.

• Guardant Health Inc shares had risen by 16.3% this quarter and gained 62.1% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 8.8% in the last three months.​

• In the last 30 days, three analysts negatively revised earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 23 "strong buy" or "buy," 2 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

• Wall Street's median 12-month price target for Guardant Health Inc is $56.00

This summary was machine generated from LSEG data April 30 at 09:52 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)